Advertisement
MET vs MFC
Which Stock Would AI Choose? MetLife (MET) vs. Manulife Financial (MFC) Stock Comparison
Key Takeaways
- MET reported strong Q1 2026 results with adjusted earnings up 18% year-over-year and adjusted ROE (return on equity) of 17%, supported by higher net investment income.
- MFC has shown superior longer-term performance, with YTD return of about 10.7% outperforming the benchmark, and a dividend yield around 3.2%.
- Both stocks operate in the life insurance sector but differ in geographic focus: MET emphasizes U.S. and Latin America, while MFC leverages strong Asia growth.
- MET trades at a lower P/E ratio (around 12-14), suggesting relative value, while MFC exhibits higher recent momentum near 52-week highs.
- Market caps stand at approximately $50B for MET and $67B for MFC, reflecting scale differences.
- Recent price action shows MFC hitting new highs amid positive sentiment, contrasting MET's post-earnings dip despite beats.
Introduction
This stock comparison examines MET (MetLife, Inc.) and MFC (Manulife Financial Corporation), two leading life insurance providers navigating interest rate shifts and economic uncertainties. Both offer diversified portfolios in insurance, annuities, and asset management, appealing to income-focused investors seeking stability and growth. Traders may find value in their relative performance amid sector rotation, while long-term holders benefit from consistent dividends and exposure to global demographics like aging populations. Recent market activity highlights contrasts in momentum and valuation, aiding decisions on positioning in financial services stocks.
MET Overview and Recent Performance
MET (MetLife, Inc.) is a global financial services leader offering life insurance, annuities, group benefits, and asset management across U.S., Asia, Latin America, and EMEA segments. In recent market activity, the stock has shown resilience with a 30-day return around 10.7%, though YTD lagging the S&P 500 at 0.38%. Q1 2026 earnings featured adjusted earnings of $1.6 billion (up 18% YoY), adjusted EPS of $2.42 (beating estimates), and adjusted ROE of 17%—at the high end of its 15-17% target. Net investment income rose 10% to $5.4 billion, driven by variable returns up 58%, while premiums and fees grew amid volume expansion. Sentiment reflects positive underwriting in group benefits and Asia, tempered by a post-earnings price dip near $78-80 from a 52-week high of $83.85. Influences include higher private equity gains and shareholder returns exceeding $1.1 billion via buybacks and dividends.
MFC Overview and Recent Performance
MFC (Manulife Financial Corporation) delivers insurance, wealth management, and retirement solutions, with strongholds in Canada, Asia, and U.S. operations via John Hancock. Recent weeks saw the stock hit 52-week highs near $40 USD (C$54+), with YTD return of 10.65% outperforming its benchmark. Over one year, returns reached 31%, driven by Asia growth and product innovation. ROE stands at approximately 11.5%, with a dividend yield of 3.2-3.3% supported by a 57% payout ratio. Key developments include U.S. sales leadership appointments and youth mental health commitments, bolstering sentiment. Performance benefits from robust operating cash flows and analyst upgrades, though Q1 2026 results are pending. Broader factors like favorable demographics in Asia and stable credit metrics (LICAT ratio implied strong) underpin momentum, contrasting minor 3-month dips.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases top-performing AI trading bots curated from hundreds available on the platform, which trade thousands of tickers across stocks, ETFs, and crypto. Only the most suitable for current conditions—based on metrics like annualized returns up to 285%, win rates of 50-88%, and profit factors to 11.7—earn a spot among the 25 trending bots out of 351 total. These bots employ diverse strategies, from momentum in semiconductors and space infrastructure to volatility plays in financial services, with examples like a finance sector bot at 83% win rate and 11.7 profit factor. Timeframes range from 15-minute scalps to swing trades, enabling adaptation to market volatility. Traders can explore and copy these for potential outperformance. Visit Trending AI Robots to review stats and subscribe.
Head-to-Head Comparison
MET and MFC share life insurance cores but diverge in models: MET focuses on U.S. group benefits (19% earnings growth) and Latin America, while MFC drives growth via Asia (high CSM—contractual service margin) and Canadian wealth. Recent momentum favors MFC (31% 1-year return vs. MET's 3%), with new highs signaling sentiment strength. Valuation trade-offs: MET's lower P/E (12-14) vs. MFC's 18 offers value, but MFC's higher ROE trajectory (11.5%) and dividend growth edge income plays. Risks include interest sensitivity for both, though MET faces U.S. regulatory scrutiny; MFC geopolitical Asia exposure. Sector-wise, both benefit from rising rates boosting NII (net interest income), but MFC's international diversification tempers U.S.-centric volatility.
Tickeron AI Verdict
Tickeron’s AI currently favors MFC due to superior trend consistency, with YTD outperformance, 52-week highs, and stronger multi-year returns amid positive analyst revisions. Factors include Asia catalysts, stable ROE, and higher dividend yield positioning it probabilistically better for momentum continuation versus MET's valuation appeal but recent lag and post-earnings pullback. Observable stability and relative strength suggest higher near-term probability of gains for MFC.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MET is a Hold and MFC is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MET’s FA Score shows that 2 FA rating(s) are green whileMFC’s FA Score has 1 green FA rating(s).
- MET’s FA Score: 2 green, 3 red.
- MFC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MET’s TA Score shows that 3 TA indicator(s) are bullish while MFC’s TA Score has 5 bullish TA indicator(s).
- MET’s TA Score: 3 bullish, 6 bearish.
- MFC’s TA Score: 5 bullish, 3 bearish.
Price Growth
MET (@Life/Health Insurance) experienced а -2.69% price change this week, while MFC (@Life/Health Insurance) price change was -1.39% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was -1.61%. For the same industry, the average monthly price growth was -3.80%, and the average quarterly price growth was +2.03%.
Reported Earning Dates
MET is expected to report earnings on Aug 05, 2026.
MFC is expected to report earnings on Aug 05, 2026.
Industries' Descriptions
@Life/Health Insurance (-1.61% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| MET | MFC | MET / MFC | |
| Capitalization | 53.3B | 64.1B | 83% |
| EBITDA | N/A | N/A | - |
| Gain YTD | 4.084 | 5.209 | 78% |
| P/E Ratio | 15.66 | 15.23 | 103% |
| Revenue | 76B | 53B | 143% |
| Total Cash | N/A | 26.7B | - |
| Total Debt | 20.2B | 14.7B | 137% |
MET | MFC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 65 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 40 Fair valued | |
PROFIT vs RISK RATING 1..100 | 48 | 15 | |
SMR RATING 1..100 | 95 | 98 | |
PRICE GROWTH RATING 1..100 | 35 | 48 | |
P/E GROWTH RATING 1..100 | 32 | 59 | |
SEASONALITY SCORE 1..100 | 34 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (30) in the Life Or Health Insurance industry is in the same range as MFC (40). This means that MET’s stock grew similarly to MFC’s over the last 12 months.
MFC's Profit vs Risk Rating (15) in the Life Or Health Insurance industry is somewhat better than the same rating for MET (48). This means that MFC’s stock grew somewhat faster than MET’s over the last 12 months.
MET's SMR Rating (95) in the Life Or Health Insurance industry is in the same range as MFC (98). This means that MET’s stock grew similarly to MFC’s over the last 12 months.
MET's Price Growth Rating (35) in the Life Or Health Insurance industry is in the same range as MFC (48). This means that MET’s stock grew similarly to MFC’s over the last 12 months.
MET's P/E Growth Rating (32) in the Life Or Health Insurance industry is in the same range as MFC (59). This means that MET’s stock grew similarly to MFC’s over the last 12 months.
| MET | MFC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 63% | 2 days ago 50% |
| Stochastic ODDS (%) | 2 days ago 60% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 66% | 2 days ago 61% |
| MACD ODDS (%) | 2 days ago 63% | 2 days ago 45% |
| TrendWeek ODDS (%) | 2 days ago 58% | 2 days ago 52% |
| TrendMonth ODDS (%) | 2 days ago 49% | 2 days ago 47% |
| Advances ODDS (%) | 15 days ago 62% | 9 days ago 63% |
| Declines ODDS (%) | 8 days ago 55% | 4 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 59% |
| Aroon ODDS (%) | 2 days ago 48% | 2 days ago 55% |
Advertisement
MET and
Correlation & Price change
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.